Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Regulatory News (REL)

Share Price Information for Relx (REL)

Share Price is delayed by 15 minutes
Get Live Data
2,602.00    -14.00 (-0.54%)
Bid:
2,601.00
Ask:
2,603.00
Spread: 2.00 (0.077%)
Market Cap: £45.85b
REL Live PriceLast checked at - London Stock Exchange

Intraday Relx Share Chart

Directorate Change

13 Feb 2025 07:15

RNS Number : 9240W
RELX PLC
13 February 2025
 

RELX PLC announces Non-Executive Director appointment and other Board changes

 

RELX PLC today announces the appointment of Andy Halford as a Non-Executive Director, with effect from the conclusion of the 2025 Annual General Meeting (AGM), to be held on 24 April 2025, subject to his election at the AGM. The Company also announces the retirement of Robert MacLeod from the Board.

 

Mr Halford is currently Chief Financial Officer of Aareal Bank, a leading international specialist property bank. Prior to joining Aareal Bank, Mr Halford was Chief Financial Officer of Standard Chartered plc from 2014 to 2024, and Chief Financial Officer of Vodafone Group Plc from 2005 to 2014. Mr Halford also served as a Non-Executive Director and Audit Committee Chair of Marks and Spencer Group plc from 2013 to 2022 and was appointed as Senior Independent Director of that board in 2018. Mr Halford qualified as a chartered accountant at Price Waterhouse LLP. He holds a Bachelor of Arts degree in Industrial Economics from Nottingham University.

 

Having served as a Non-Executive Director since 2016, and currently holding the role of Chair of the Remuneration Committee, Robert MacLeod will retire from the Board following the conclusion of the Company's AGM. Alistair Cox will succeed Mr MacLeod as Chair of the Remuneration Committee with effect from the conclusion of the AGM, subject to his re-election by shareholders at the AGM. 

 

Commenting on these changes, Paul Walker, Chair said: 

"I am very much looking forward to Andy joining our Board. Andy is a highly accomplished and well-respected senior executive with a strong financial background and reputation for delivering shareholder value in major, complex, international organisations. With his considerable experience, I am confident Andy will make a significant contribution to the RELX Board.

On behalf of the Directors, I would like to thank Robert for the valuable service that he has given RELX, as a member of the Board and in performing the role of Chair of the Remuneration Committee. Robert leaves RELX with our very best wishes for the future."

 

Save as disclosed above, there are no additional details to disclose under Listing Rule 6.4.8R (1) to (6) in respect of the appointment of Mr Halford.

 

 

 

-ENDS-

 

 

ENQUIRIES:

 

Colin Tennant (Investors)

+44 (0)20 7166 5751

Paul Abrahams (Media)

+44 (0)20 7166 5724

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDDBXBDGUD
Date   Source Headline
3rd Mar 20255:24 pmRNSTransaction in Own Shares
3rd Mar 20251:20 pmRNSTotal Voting Rights
28th Feb 20255:04 pmRNSTransaction in Own Shares
27th Feb 20255:11 pmRNSTransaction in Own Shares
27th Feb 20252:30 pmRNSAdditional Listing
26th Feb 20255:34 pmRNSTransaction in Own Shares
25th Feb 20255:32 pmRNSTransaction in Own Shares
24th Feb 20255:01 pmRNSTransaction in Own Shares
21st Feb 20255:48 pmRNSTransaction in Own Shares
20th Feb 202511:37 amRNSAnnual Financial Report
19th Feb 20257:00 amRNSDirector/PDMR Shareholding
18th Feb 20256:29 pmRNSDirector/PDMR Shareholding
18th Feb 20255:48 pmRNSTransaction in Own Shares
17th Feb 20255:15 pmRNSTransaction in Own Shares
17th Feb 202511:58 amRNSAdditional Listing
14th Feb 20255:38 pmRNSTransaction in Own Shares
13th Feb 20255:35 pmRNSTransaction in Own Shares
13th Feb 202510:00 amBUSAnnouncement of Non-Discretionary Share Buyback Programme
13th Feb 20257:15 amRNSDirectorate Change
13th Feb 20257:00 amRNSRELX 2024 RESULTS
7th Feb 20255:14 pmRNSTransaction in Own Shares
6th Feb 20255:14 pmRNSTransaction in Own Shares
5th Feb 20255:34 pmRNSTransaction in Own Shares
4th Feb 20255:09 pmRNSTransaction in Own Shares
3rd Feb 20255:38 pmRNSTotal Voting Rights
3rd Feb 20255:26 pmRNSTransaction in Own Shares
31st Jan 20255:27 pmRNSTransaction in Own Shares
30th Jan 20254:58 pmRNSTransaction in Own Shares
29th Jan 20256:26 pmRNSTransaction in Own Shares
28th Jan 20255:14 pmRNSTransaction in Own Shares
27th Jan 20254:54 pmRNSTransaction in Own Shares
27th Jan 20254:47 pmRNSAdditional Listing
27th Jan 20252:24 pmRNSDirector Declaration
24th Jan 20254:59 pmRNSTransaction in Own Shares
23rd Jan 20255:16 pmRNSTransaction in Own Shares
22nd Jan 20255:51 pmRNSTransaction in Own Shares
21st Jan 20255:21 pmRNSTransaction in Own Shares
20th Jan 20255:03 pmRNSTransaction in Own Shares
17th Jan 20254:57 pmRNSTransaction in Own Shares
16th Jan 20255:11 pmRNSTransaction in Own Shares
15th Jan 20255:30 pmRNSTransaction in Own Shares
14th Jan 20255:01 pmRNSTransaction in Own Shares
13th Jan 20255:34 pmRNSTransaction in Own Shares
10th Jan 20254:57 pmRNSTransaction in Own Shares
9th Jan 20255:39 pmRNSTransaction in Own Shares
8th Jan 20255:03 pmRNSTransaction in Own Shares
7th Jan 20255:05 pmRNSTransaction in Own Shares
6th Jan 20255:26 pmRNSTransaction in Own Shares
3rd Jan 20255:28 pmRNSTransaction in Own Shares
2nd Jan 20255:33 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.